Pfizer standalone net profit declines 12.02% in the September 2017 quarter

Sales rise 6.63% to Rs 571.11 crore

Net profit of Pfizer declined 12.02% to Rs 111.15 crore in the quarter ended September 2017 as against Rs 126.33 crore during the previous quarter ended September 2016. Sales rose 6.63% to Rs 571.11 crore in the quarter ended September 2017 as against Rs 535.60 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales571.11535.60 7 OPM %29.2817.03 -PBDT190.79115.33 65 PBT174.7799.24 76 NP111.15126.33 -12

Powered by Capital Market - Live News